Molecular Breeding
Global Molecular Breeding Market to Reach $7.1 Billion by 2027
Amid the COVID-19 crisis, the global market for Molecular Breeding estimated at US$2.4 Billion in the year 2020, is projected to reach a revised size of US$7.1 Billion by 2027, growing at a CAGR of 16.7% over the analysis period 2020-2027. Marker-Assisted Selection (MAS), one of the segments analyzed in the report, is projected to record a 17.3% CAGR and reach US$2.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the QTL Mapping segment is readjusted to a revised 16.3% CAGR for the next 7-year period.
The U.S. Market is Estimated at $711.2 Million, While China is Forecast to Grow at 16.1% CAGR
The Molecular Breeding market in the U.S. is estimated at US$711.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2027 trailing a CAGR of 16.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.9% and 14.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.3% CAGR.
Marker-Assisted Backcrossing (MABC) Segment to Record 15.4% CAGR
In the global Marker-Assisted Backcrossing (MABC) segment, USA, Canada, Japan, China and Europe will drive the 15.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$344.6 Million in the year 2020 will reach a projected size of US$926.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$852.2 Million by the year 2027.
Select Competitors (Total 32 Featured) -
- Eurofins Scientific
- Illumina
- LGC Limited
- Thermo Fisher Scientific, Inc.
- SGS SA
- DanBred
- Intertek Group Plc
- LemnaTec GmbH
- Charles River Laboratories
- Slipstream Automation
- Fruitbreedomics
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.
The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.
Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
- I. METHODOLOGY
- II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- Global Competitor Market Shares
- Molecular Breeding Competitor Market Share Scenario Worldwide (in %): 2020E
- Global Competitor Market Shares by Segment
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
- 4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Current & Future Analysis for Molecular Breeding by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- TABLE 2: World Historic Review for Molecular Breeding by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 3: World 15-Year Perspective for Molecular Breeding by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
- TABLE 4: World Current & Future Analysis for Marker-Assisted Selection (MAS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- TABLE 5: World Historic Review for Marker-Assisted Selection (MAS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 6: World 15-Year Perspective for Marker-Assisted Selection (MAS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
- TABLE 7: World Current & Future Analysis for QTL Mapping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- TABLE 8: World Historic Review for QTL Mapping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 9: World 15-Year Perspective for QTL Mapping by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
- TABLE 10: World Current & Future Analysis for Marker-Assisted Backcrossing (MABC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- TABLE 11: World Historic Review for Marker-Assisted Backcrossing (MABC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 12: World 15-Year Perspective for Marker-Assisted Backcrossing (MABC) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
- TABLE 13: World Current & Future Analysis for Genomic Selection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- TABLE 14: World Historic Review for Genomic Selection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 15: World 15-Year Perspective for Genomic Selection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
- TABLE 16: World Current & Future Analysis for Other Processes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- TABLE 17: World Historic Review for Other Processes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 18: World 15-Year Perspective for Other Processes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
- TABLE 19: World Current & Future Analysis for Single Nucleotide Polymorphism (SNP) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- TABLE 20: World Historic Review for Single Nucleotide Polymorphism (SNP) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 21: World 15-Year Perspective for Single Nucleotide Polymorphism (SNP) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
- TABLE 22: World Current & Future Analysis for Simple Sequence Repeats (SSR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- TABLE 23: World Historic Review for Simple Sequence Repeats (SSR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 24: World 15-Year Perspective for Simple Sequence Repeats (SSR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
- TABLE 25: World Current & Future Analysis for Crop Breeding by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- TABLE 26: World Historic Review for Crop Breeding by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 27: World 15-Year Perspective for Crop Breeding by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
- TABLE 28: World Current & Future Analysis for Livestock by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- TABLE 29: World Historic Review for Livestock by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 30: World 15-Year Perspective for Livestock by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
- III. MARKET ANALYSIS
- UNITED STATES
- Market Facts & Figures
- Market Analytics
- TABLE 31: USA Current & Future Analysis for Molecular Breeding by Process - Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection and Other Processes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 32: USA Historic Review for Molecular Breeding by Process - Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection and Other Processes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 33: USA 15-Year Perspective for Molecular Breeding by Process - Percentage Breakdown of Value Sales for Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection and Other Processes for the Years 2012, 2020 & 2027
- TABLE 34: USA Current & Future Analysis for Molecular Breeding by Marker - Single Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 35: USA Historic Review for Molecular Breeding by Marker - Single Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 36: USA 15-Year Perspective for Molecular Breeding by Marker - Percentage Breakdown of Value Sales for Single Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR) for the Years 2012, 2020 & 2027
- TABLE 37: USA Current & Future Analysis for Molecular Breeding by Application - Crop Breeding and Livestock - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 38: USA Historic Review for Molecular Breeding by Application - Crop Breeding and Livestock Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 39: USA 15-Year Perspective for Molecular Breeding by Application - Percentage Breakdown of Value Sales for Crop Breeding and Livestock for the Years 2012, 2020 & 2027
- CANADA
- TABLE 40: Canada Current & Future Analysis for Molecular Breeding by Process - Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection and Other Processes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 41: Canada Historic Review for Molecular Breeding by Process - Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection and Other Processes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 42: Canada 15-Year Perspective for Molecular Breeding by Process - Percentage Breakdown of Value Sales for Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection and Other Processes for the Years 2012, 2020 & 2027
- TABLE 43: Canada Current & Future Analysis for Molecular Breeding by Marker - Single Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 44: Canada Historic Review for Molecular Breeding by Marker - Single Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 45: Canada 15-Year Perspective for Molecular Breeding by Marker - Percentage Breakdown of Value Sales for Single Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR) for the Years 2012, 2020 & 2027
- TABLE 46: Canada Current & Future Analysis for Molecular Breeding by Application - Crop Breeding and Livestock - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 47: Canada Historic Review for Molecular Breeding by Application - Crop Breeding and Livestock Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 48: Canada 15-Year Perspective for Molecular Breeding by Application - Percentage Breakdown of Value Sales for Crop Breeding and Livestock for the Years 2012, 2020 & 2027
- JAPAN
- TABLE 49: Japan Current & Future Analysis for Molecular Breeding by Process - Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection and Other Processes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 50: Japan Historic Review for Molecular Breeding by Process - Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection and Other Processes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 51: Japan 15-Year Perspective for Molecular Breeding by Process - Percentage Breakdown of Value Sales for Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection and Other Processes for the Years 2012, 2020 & 2027
- TABLE 52: Japan Current & Future Analysis for Molecular Breeding by Marker - Single Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 53: Japan Historic Review for Molecular Breeding by Marker - Single Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 54: Japan 15-Year Perspective for Molecular Breeding by Marker - Percentage Breakdown of Value Sales for Single Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR) for the Years 2012, 2020 & 2027
- TABLE 55: Japan Current & Future Analysis for Molecular Breeding by Application - Crop Breeding and Livestock - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 56: Japan Historic Review for Molecular Breeding by Application - Crop Breeding and Livestock Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 57: Japan 15-Year Perspective for Molecular Breeding by Application - Percentage Breakdown of Value Sales for Crop Breeding and Livestock for the Years 2012, 2020 & 2027
- CHINA
- TABLE 58: China Current & Future Analysis for Molecular Breeding by Process - Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection and Other Processes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 59: China Historic Review for Molecular Breeding by Process - Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection and Other Processes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 60: China 15-Year Perspective for Molecular Breeding by Process - Percentage Breakdown of Value Sales for Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection and Other Processes for the Years 2012, 2020 & 2027
- TABLE 61: China Current & Future Analysis for Molecular Breeding by Marker - Single Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 62: China Historic Review for Molecular Breeding by Marker - Single Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 63: China 15-Year Perspective for Molecular Breeding by Marker - Percentage Breakdown of Value Sales for Single Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR) for the Years 2012, 2020 & 2027
- TABLE 64: China Current & Future Analysis for Molecular Breeding by Application - Crop Breeding and Livestock - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 65: China Historic Review for Molecular Breeding by Application - Crop Breeding and Livestock Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 66: China 15-Year Perspective for Molecular Breeding by Application - Percentage Breakdown of Value Sales for Crop Breeding and Livestock for the Years 2012, 2020 & 2027
- EUROPE
- Market Facts & Figures
- Market Analytics
- TABLE 67: Europe Current & Future Analysis for Molecular Breeding by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- TABLE 68: Europe Historic Review for Molecular Breeding by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 69: Europe 15-Year Perspective for Molecular Breeding by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
- TABLE 70: Europe Current & Future Analysis for Molecular Breeding by Process - Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection and Other Processes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 71: Europe Historic Review for Molecular Breeding by Process - Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection and Other Processes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 72: Europe 15-Year Perspective for Molecular Breeding by Process - Percentage Breakdown of Value Sales for Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection and Other Processes for the Years 2012, 2020 & 2027
- TABLE 73: Europe Current & Future Analysis for Molecular Breeding by Marker - Single Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 74: Europe Historic Review for Molecular Breeding by Marker - Single Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 75: Europe 15-Year Perspective for Molecular Breeding by Marker - Percentage Breakdown of Value Sales for Single Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR) for the Years 2012, 2020 & 2027
- TABLE 76: Europe Current & Future Analysis for Molecular Breeding by Application - Crop Breeding and Livestock - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 77: Europe Historic Review for Molecular Breeding by Application - Crop Breeding and Livestock Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 78: Europe 15-Year Perspective for Molecular Breeding by Application - Percentage Breakdown of Value Sales for Crop Breeding and Livestock for the Years 2012, 2020 & 2027
- FRANCE
- TABLE 79: France Current & Future Analysis for Molecular Breeding by Process - Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection and Other Processes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 80: France Historic Review for Molecular Breeding by Process - Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection and Other Processes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 81: France 15-Year Perspective for Molecular Breeding by Process - Percentage Breakdown of Value Sales for Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection and Other Processes for the Years 2012, 2020 & 2027
- TABLE 82: France Current & Future Analysis for Molecular Breeding by Marker - Single Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 83: France Historic Review for Molecular Breeding by Marker - Single Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 84: France 15-Year Perspective for Molecular Breeding by Marker - Percentage Breakdown of Value Sales for Single Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR) for the Years 2012, 2020 & 2027
- TABLE 85: France Current & Future Analysis for Molecular Breeding by Application - Crop Breeding and Livestock - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 86: France Historic Review for Molecular Breeding by Application - Crop Breeding and Livestock Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 87: France 15-Year Perspective for Molecular Breeding by Application - Percentage Breakdown of Value Sales for Crop Breeding and Livestock for the Years 2012, 2020 & 2027
- GERMANY
- TABLE 88: Germany Current & Future Analysis for Molecular Breeding by Process - Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection and Other Processes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 89: Germany Historic Review for Molecular Breeding by Process - Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection and Other Processes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 90: Germany 15-Year Perspective for Molecular Breeding by Process - Percentage Breakdown of Value Sales for Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection and Other Processes for the Years 2012, 2020 & 2027
- TABLE 91: Germany Current & Future Analysis for Molecular Breeding by Marker - Single Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 92: Germany Historic Review for Molecular Breeding by Marker - Single Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 93: Germany 15-Year Perspective for Molecular Breeding by Marker - Percentage Breakdown of Value Sales for Single Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR) for the Years 2012, 2020 & 2027
- TABLE 94: Germany Current & Future Analysis for Molecular Breeding by Application - Crop Breeding and Livestock - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 95: Germany Historic Review for Molecular Breeding by Application - Crop Breeding and Livestock Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 96: Germany 15-Year Perspective for Molecular Breeding by Application - Percentage Breakdown of Value Sales for Crop Breeding and Livestock for the Years 2012, 2020 & 2027
- ITALY
- TABLE 97: Italy Current & Future Analysis for Molecular Breeding by Process - Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection and Other Processes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 98: Italy Historic Review for Molecular Breeding by Process - Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection and Other Processes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 99: Italy 15-Year Perspective for Molecular Breeding by Process - Percentage Breakdown of Value Sales for Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection and Other Processes for the Years 2012, 2020 & 2027
- TABLE 100: Italy Current & Future Analysis for Molecular Breeding by Marker - Single Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR) - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR